Skip to content

Clinical trials

Periodontal Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Periodontal Diseases Country / region: United States Clear all

91 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20032
20042
20053
20061
20072
20083
20091
20107
20111
20126
20134
20143
20156
20163
20173
20188
20192
20201
20215
20223
20234
20246
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed62
Recruiting13
Unknown status6
Active, not recruiting3
Terminated3
Enrolling by invitation2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Dental and Craniofacial Research (NIDCR)4
The Forsyth Institute4
The University of Texas Health Science Center at San Antonio4
University of Michigan4
University of North Carolina, Chapel Hill4
The University of Texas Health Science Center, Houston3
University of Nebraska3
Boston University2
Case Western Reserve University2
Glo Science, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Periodontal Diseases91
Periodontitis21
Gingivitis11
Diabetes Mellitus8
Diabetes Mellitus, Type 27
Inflammation7
Dental Caries6
Gingival Diseases6
Cardiovascular Diseases4
Dental Plaque4

Trials

Showing 1 to 25 of 91. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.